Ac Immune Sa

This study is testing an experimental vaccine called ACI-24.060. It aims to train the body's immune system to target and clear amyloid plaques, a hallmark of Alzheimer's disease. The trial will enroll 176 people in two groups: those with very early Alzheimer's symptoms and adults…

This early-stage study is testing a new type of brain scan to see if it can safely and reliably detect clumps of a protein called alpha-synuclein in the brain. These protein clumps are involved in Parkinson's disease, Lewy body dementia, and multiple system atrophy. Researchers w…

This is a first-in-human study to check the safety and tolerability of a new drug called ACI-19764, which is designed to target the brain. It will involve 78 healthy volunteers to see how the body absorbs and processes the drug at different dose levels. The main goal is to gather…